Sign in
4

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001415889-23-013337

Director acquired 2,986 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DIXON WENDY L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-15 Grant or award : show line 1 in the form +2,986 $3.60 $10,750 30,758 D
Loading xslF345X05/form4-09182023_090941.xml…